ATTACC PI Dr. Ryan Zarychanski is being recognized as Doctors Manitoba Physician of the Year. Congratulations… https://t.co/XAVeM8k1Yt

RT @giovannilandoni: Thanks to the authors of these 6 high quality RCTs we were able to document that full anticoagulation is improving… https://t.co/jxBD7T6RAd

⬇️ Important summary on the use of antithrombotic agents in patients with COVID-19 https://t.co/8FjBwHCfXL

RT @MayoAntiCoag: 🔥 This week we'll be discussing the hot topic of VTE Prophylaxis in COVID-19 ‼️ Our latest protocol is published o… https://t.co/nt1zMSBYll

RT @macky_neal: Practice changing work from the #mpRCT and efforts of @ACTIV4a @ATTACC_COVID @remap_cap. @nih_nhlbi @NIH guidelines… https://t.co/6sv5PHgYAN

RT @RZarychanski: A step forward - therapeutic LWMH recommended for hospitalized non-critically I’ll patients with COVID19… https://t.co/iwec4CXq2Y

RT @laveenamunshi: @ecgoligher @PatrickLawlerMD and @RZarychanski present the results of the ATTACC trial, platform trials and the glo… https://t.co/P0S7OLViEr

RT @CCCForum: #CCCF2021 Keynote address Monday December 6, 4:45pm Anticoagulation in COVID-19 by @RZarychanski @ecgoligher… https://t.co/XBtVrUHe1c

RT @StephenLap: Superb @UofT_DoM Grand Rounds by @ecgoligher & @PatrickLawlerMD on the background, statistical approach & interpre… https://t.co/lIhfOBAGjS

ATTACC Mexico country lead and investigator Dr. Jorge Escobedo presented the results of the anticoagulation mpRCT (… https://t.co/N4nqtT8Kkp